Summary of - Differential effects of dietary polyphenols on oral pharmacokinetics of cyclin-dependent kinase inhibitors in rats: a mechanistic framework for in vitro–in vivo extrapolation
2024
- 1Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage1
- Abstract Views1
Article Description
Study Background: Cyclin-dependent kinase inhibitors exhibit low bioavailability due to its rapid first-pass metabolism and P-gp mediated intestinal efflux.Research goal and Objective: The current study investigated the impact of dietary polyphenols on the oral pharmacokinetics of cyclin-dependent kinase inhibitors.Methodological approach : An approach combining molecular docking; in vitro preclinical assay using rat liver microsomes and Caco-2 cell monolayers and in vivo, pharmacokinetic experiment was used to study the interaction. Results and Discoveries : Commonly consumed dietary polyphenols curcumin and quercetin significantly inhibited both intestinal efflux and CYP3A4-mediated metabolism of palbociclib and ribociclib (p < 0.05). In rats pretreated with curcumin, Cmax of palbociclib exhibited a 5.13% increase, while the AUC0-24h of ribociclib showed a significant increase of 18.83% (p < 0.05). Conclusions: The utilization of curcumin as a bioenhancer can enhance the bioavailability of dual substrates of P-gp and CYP3A4. Whereas, quercetin does not exhibit any bio enhancing activity specific to inhibition of P-gp and CYP3A4. Publication DateFebruary 2024 Recommended CitationPatil PH, Desai MP, Birangal S, Gautham Shenoy G, Jagadish PC. Differential effects of dietary polyphenols on oral pharmacokinetics of cyclin-dependent kinase inhibitors in rats: a mechanistic framework for in vitro–in vivo extrapolation. Journal of Pharmacy and Pharmacology. 2024 Feb 1;76(2):93-105.DOI/Link : https://doi.org/10.1093/jpp/rgad115
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know